Clinical trial
Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With…
NCT00301067 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00301067 |
|---|---|
| Title | Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma |
| Official title | A Phase I/II Study of High-Dose Calcitriol in Combination With Temozolomide for Patients With Metastatic Melanoma |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Melanoma |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Calcitriol, Temozolomide |
| Enrollment | 20 |
| Start date | Jan 30, 2005 |
| Primary completion | Apr 5, 2012 |
| Completion | Jul 9, 2012 |
| First posted | Mar 10, 2006 |
| Last update posted | Jun 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: